5nilbog t1_j3dl3qa wrote on January 7, 2023 at 8:29 PM Reply to A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii Exactly “the incidence of COVID-19 was similar in both the HCQ group and control.” Permalink 43
5nilbog t1_j3dl3qa wrote
Reply to A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
Exactly “the incidence of COVID-19 was similar in both the HCQ group and control.”